Clinical management of tacrolimus drug interactions in renal transplant patients.
Moreno
M
M
Nephrology and Biochemistry Service, Hospital 12 de Octubre, Madrid, Spain.
Latorre
A
A
Manzanares
C
C
Morales
E
E
Herrero
J C
JC
Dominguez-Gil
B
B
Carreño
A
A
Cubas
A
A
Delgado
M
M
Andres
A
A
Morales
J M
JM
D000328:Adult; D000368:Aged; D000935:Antifungal Agents / Q000009:adverse effects*; D002177:Candidiasis / Q000188:drug therapy; D004347:Drug Interactions; D004917:Erythromycin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000097:blood; D007654:Ketoconazole / Q000009:adverse effects*; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D010672:Phenytoin / Q000627:therapeutic use; D011183:Postoperative Complications; D012293:Rifampin / Q000627:therapeutic use; D016559:Tacrolimus / Q000009:adverse effects* / Q000097:blood
D000935:Antifungal Agents; D007166:Immunosuppressive Agents; D010672:Phenytoin; D004917:Erythromycin; D007654:Ketoconazole; D012293:Rifampin; D016559:Tacrolimus